Brief: Todos Medical Announces Data Lock In Tollovir Phase 2 Clinical Trial
24/01/2022 14:24
Jan 24 (Reuters) - Todos Medical Ltd TOMDF.PK :
* TODOS MEDICAL ANNOUNCES DATA LOCK IN TOLLOVIR PHASE 2
CLINICAL
TRIAL FOR THE TREATMENT OF HOSPITALIZED COVID-19 PATIENTS
* TODOS MEDICAL LTD - WILL RELEASE RESULTS ON THURSDAY,
JANUARY
27TH, 2022
Source text for Eikon: ID:nGNX9bCPdX
Further company coverage: TOMDF.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Todos Medical
See all newsBrief: Todos Medical Enters Into Exclusive Worldwide Automated Retail Supply Agreement With Smart Automated Retail Network
Brief: Todos Medical Clia/Cap Lab Provista Submits Emergency Use Authorization Application For Monkeypox Pcr Test To Us FDA
Brief: Todos Medical Provides Corporate Update
Brief: Todos Medical Enters Into $50 Mln Contract To Supply Tollovid, CBD Products To Retail Distributor Company Nerd Hemp
Brief: Todos Medical Establishes Botanical Supplement Manufacturing Capabilities